Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Product Differences Necessitate Some US FDA Inconsistency In Rare Diseases, Center Directors Say
Jul 08 2022
•
By
Derrick Gingery
Inconsistency is not the same as scientific disagreement, CDER Director Patrizia Cavazzoni said. • Source: Shutterstock
More from Product Reviews
More from Pink Sheet